Form 4: Reneo Pharmaceuticals Insider Buys Over 400,000 Shares

Braden Michael Leonard, a director and 10% owner of Reneo Pharmaceuticals, acquired over 400,000 shares of common stock through BML Investment Partners, L.P.

Summary

• On May 14, 2024, Braden Michael Leonard, a director and 10% owner of Reneo Pharmaceuticals, indirectly acquired shares of RPHM common stock.
• The purchases were made through BML Investment Partners, L.P., where BML Capital Management, LLC serves as the general partner and Mr. Leonard is the managing member.
• A total of 79,281 shares were purchased at a weighted average price of $1.56, and 335,000 shares were purchased at a weighted average price of $1.54.
• Following these transactions, Mr. Leonard indirectly holds 2,672,194 shares through BML Investment Partners, L.P., and directly holds 1,020,769 shares.

Sentiment

Score: 7

Explanation: Insider buying is generally viewed as a positive signal, suggesting confidence in the company's prospects. The large volume of shares purchased further strengthens this positive sentiment.

Positives

• An insider's purchase of a significant number of shares can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider buying is often monitored as an indicator of management's and major shareholders' sentiment about the company's prospects, relative to the current stock price. It can be a positive signal, but should be considered alongside other factors.

Key Dates